Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2017: 3.556

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 49, Issue 7


Good performance of an immunoassay based method for nevirapine measurements in human breast milk

Kirsten Salado-Rasmussen / Zahra Persson Theilgaard / Mercy Chiduo / Court Pedersen / Jan Gerstoft / Terese Lea Katzenstein
Published Online: 2011-04-20 | DOI: https://doi.org/10.1515/CCLM.2011.184


Background: Understanding the distribution of antiretro-virals in breastfeeding HIV-positive mothers is essential, both for prevention of mother-to-child HIV transmission and for research on the development of drug resistance. The ARK nevirapine (NVP)-test is an immunoassay method for nevirapine measurements, developed and validated for plasma use. In this study, the ARK NVP-test was evaluated for measurement of nevirapine concentrations in breast milk. High performance liquid chromatography (HPLC) is the method currently used to determine nevirapine in breast milk. This method, however, requires complicated extraction techniques. The ARK method employs an immunoassay technology and requires a small sample volume (40 μL) and no pre-treatment of the samples.

Methods: Commercial enzyme and antibody were used and calibration standards and quality controls were prepared from pooled breast milk from HIV-uninfected women. Clinical samples from HIV-infected women receiving a single-dose of nevirapine were analyzed.

Results: Precision and accuracy were evaluated with two concentrations of quality control materials analyzed in three replicates on four different days and was <4%, and between 96.5% and 104.6%, respectively. Clinical samples were analyzed and CVs ranged from 0.0% to 11.1%. The median nevirapine concentration in breast milk 1 week post-partum was 0.29 μg/mL (range 0.11–0.90 μg/mL) in women treated with a single-dose of nevirapine.

Conclusions: The ease of use and small sample volume makes the ARK assay an attractive alternative to HPLC analyses for determinations of nevirapine concentrations in breast milk.

Keywords: antiretroviral drug; breast milk; immunoassay; nevirapine

About the article

Corresponding author: Kirsten Salado-Rasmussen, MD, Classensgade 67, 6.tv, 2100 Copenhagen, Denmark Phone: +45 22816717

Received: 2010-11-08

Accepted: 2011-02-06

Published Online: 2011-04-20

Published in Print: 2011-07-01

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 49, Issue 7, Pages 1171–1175, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2011.184.

Export Citation

©2011 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Alemseged Abdissa, Lubbe Wiesner, Helen McIlleron, Henrik Friis, Åse Bengård Andersen, and Pernille Kaestel
Journal of the International AIDS Society, 2014, Volume 17, Number 1, Page 18979
Kirsten Salado-Rasmussen, Zahra P. Theilgaard, Mercy G. Chiduo, Ib C. Bygbjerg, Jan Gerstoft, Margrethe Lüneborg-Nielsen, Martha Lemnge, Terese L. Katzenstein, and Soren Gantt
PLOS ONE, 2015, Volume 10, Number 3, Page e0121111
Robin DiFrancesco, Getrude Maduke, Rutva Patel, Charlene R Taylor, and Gene D Morse
Bioanalysis, 2013, Volume 5, Number 3, Page 351

Comments (0)

Please log in or register to comment.
Log in